<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many aspects of Epstein-Barr virus (EBV) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology have been studied in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>)-derived cell lines </plain></SENT>
<SENT sid="1" pm="."><plain>However, in tissue culture, patterns of gene expression and CpG [corrected] methylation often change and <z:mp ids='MP_0001799'>viral</z:mp> strain selection may occur </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, 10 cases of snap-frozen endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are characterized in terms of <z:mp ids='MP_0001799'>viral</z:mp> gene expression, promoter usage, methylation, and <z:mp ids='MP_0001799'>viral</z:mp> strain </plain></SENT>
<SENT sid="3" pm="."><plain>EBNA1 and BamHI-A rightward transcripts (BART) were detected in 7 of 7 and LMP2A transcripts in 5 of 7 tumors with well-preserved <z:chebi fb="40" ids="33697">RNA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Transcripts for the other EBNAs and for LMP1 were not detected in any <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> differ from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines in that they lack a variety of lytic cycle transcripts </plain></SENT>
<SENT sid="6" pm="."><plain>This pattern of <z:mp ids='MP_0001799'>viral</z:mp> gene expression in endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> is similar to that reported in peripheral blood mononuclear cells (PBMCs) from healthy EBV-seropositive individuals </plain></SENT>
<SENT sid="7" pm="."><plain>EBNA1 transcripts originated from the Q promoter (Qp) but not C, W, or F promoters that drive transcription of EBNA1 in other circumstances </plain></SENT>
<SENT sid="8" pm="."><plain>Whereas Cp has been previously shown to be entirely CpG methylated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, <z:chebi fb="0" ids="17137">bisulfite</z:chebi> genomic sequencing showed virtually no methylation in Qp </plain></SENT>
<SENT sid="9" pm="."><plain>Type-A EBV was detected in 6 of 10 and type B in 4 of 10 cases </plain></SENT>
<SENT sid="10" pm="."><plain>A previously reported 30bp deletion variant in the carboxyl terminal of LMP1 gene was detected in 5 of 10 cases </plain></SENT>
<SENT sid="11" pm="."><plain>The association with both A and B strains contrasts with EBV-associated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, and post-transplant <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e>, which are much more consistently associated with A strain virus </plain></SENT>
</text></document>